Products for Research Use Only

Reverse transcription workflows

cDNA Synthesis Kits for Gene Expression and qPCR Analysis

cDNA synthesis kits contain reverse transcriptase, primers, nucleotides, buffers and supporting reagents used to convert RNA into complementary DNA. Researchers use them before qPCR, cloning, sequencing and transcript-analysis workflows because DNA is more compatible with many amplification methods. Compare kits by RNA input, priming strategy, enzyme processivity, reaction temperature, inhibitor tolerance, transcript length, genomic-DNA removal, throughput and reaction count.

Product catalog

Browse cDNA Synthesis Kits

Compare product names, catalog numbers, available sizes, pricing, and product specifications.

How does cDNA synthesis support gene expression analysis?

Reverse transcription uses an RNA-dependent DNA polymerase to synthesize complementary DNA from an RNA template. Priming may rely on oligo-dT for polyadenylated RNA, random primers for broad transcript coverage or gene-specific primers for selected targets. The priming method influences transcript representation and downstream interpretation.

Researchers prepare cDNA for relative and absolute qPCR, endpoint PCR, cloning and some library-preparation workflows. A high-temperature, processive enzyme can improve synthesis across structured RNA and longer transcripts. One-step workflows combine reverse transcription and amplification, while two-step workflows create reusable cDNA for multiple assays.

RNA integrity, contamination, input amount and reverse-transcription efficiency are major sources of variation. Genomic DNA can produce false amplification if assays do not span exon junctions. No-reverse-transcriptase controls, consistent RNA input and validated reference genes help distinguish biological expression changes from preparation artifacts.

Buying and selection guide

How to choose a cDNA synthesis kit

Match the enzyme and priming strategy to the RNA type, target length and downstream assay. The same cDNA preparation may not represent every RNA class equally.

01

Choose the priming strategy

Use oligo-dT, random, gene-specific or specialized small-RNA primers according to the targets.

02

Match RNA input

Confirm the supported quantity and whether total RNA, purified mRNA or low-input samples are suitable.

03

Review reaction temperature

Higher-temperature enzymes can improve performance with structured RNA and reduce secondary structure.

04

Check genomic-DNA control

Select integrated DNA removal or plan a separate DNase step when contamination is likely.

05

Consider downstream reuse

Choose two-step synthesis when the same cDNA will support several qPCR assays.

06

Plan technical controls

Include no-template and no-reverse-transcriptase controls and standardize RNA input across samples.

Frequently asked questions about cDNA synthesis kits

These questions cover primers, RNA quality, genomic DNA and common reasons for inconsistent reverse transcription.

What is the difference between oligo-dT and random primers?

Oligo-dT binds poly(A) tails and enriches messenger RNA-derived cDNA, while random primers bind throughout many RNA molecules and provide broader coverage. Random priming can better represent degraded RNA but may also reverse-transcribe abundant noncoding RNA.

When should gene-specific primers be used?

They are useful when only one or a few known RNA targets are needed or when transcript-specific reverse transcription improves sensitivity. They limit reuse of the cDNA for unrelated targets.

Why is a no-reverse-transcriptase control important?

It reveals amplification caused by residual genomic DNA rather than RNA-derived cDNA. A signal in this control suggests that DNA removal or assay design should be improved.

Can degraded RNA be used for cDNA synthesis?

Partially degraded RNA may still support short amplicons, especially with random priming, but transcript coverage and comparability can be biased. RNA quality should be assessed and kept similar across samples.

Why are replicate cDNA reactions variable?

Variation can arise from inaccurate low-volume pipetting, RNA inhibitors, inconsistent input, incomplete mixing or enzyme handling. Master mixes and equal RNA quantities improve reproducibility.

Can the same cDNA be used for many qPCR targets?

Yes in a two-step workflow, provided the priming method captured those transcripts and the cDNA is stored appropriately. Avoid repeated freeze-thaw cycles and excessive dilution outside validated conditions.

How much RNA should be used?

Use an amount within the kit's supported range and keep input consistent between samples. Too much RNA can introduce inhibitors, while too little may increase stochastic variation for low-abundance targets.

Does reverse transcription efficiency affect fold-change results?

Yes. Differences in RNA quality, inhibitors or priming can create apparent expression changes. Process samples consistently, use suitable reference genes and consider adding an external RNA control when technical efficiency must be monitored.